CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA in gene therapy
CEVEC Pharmaceuticals GmbH MC Services AG Dr. Ulrich Kettling Dr. Solveigh M?hler Chief Business Officer Public Relations T.: +49 221 460 208 00 E.: email@example.com T.: +49 211 529 252 19 E.: firstname.lastname@example.org ? ? ?
08.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de